Viewing Study NCT05627635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-05-18 @ 1:45 PM
Study NCT ID: NCT05627635
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-07
First Post: 2022-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colon Adenocarcinoma View
None Metastatic Colorectal Adenocarcinoma View
None Metastatic Microsatellite Stable Colorectal Carcinoma View
None Metastatic Rectal Adenocarcinoma View
None Stage IV Colon Cancer AJCC v8 View
None Stage IV Colorectal Cancer AJCC v8 View
None Stage IV Rectal Cancer AJCC v8 View
Keywords: